The 50 Insider
-
GW Pharmaceuticals raises $345.2m development capital
GW Pharmaceuticals, a Cambridge company going great guns in the US with its cannabis-based products, has raised $345.23 million from a public... Read More
-
Ontix harnesses CCS technology for London project
Cambridge Communication Systems (CCS) reveals that telecoms infrastructure provider Ontix has joined its lead customer programme for the introduction... Read More
-
UAE logistics giant takes Darktrace cyber solution
Tristar, a major logistics provider in the United Arab Emirates, has deployed Cambridge company Darktrace’s AI-driven cyber defence technology to... Read More
-
Owlstone Medical adds five to Scientific Advisory Board
Owlstone Medical, the Cambridge diagnostics company developing a breathalyser for disease, has expanded its Scientific Advisory Board with the... Read More
-
ScottishPower to trial Aveillant radar solution
ScottishPower Renewables has partnered with Cambridge-based Aveillant, part of the Thales Group, to test a pioneering new radar system that aims to... Read More
-
Cancer models platform eliminating barriers for drug discovery researchers
Cambridge-based Repositive has introduced new features to its Cancer Models Platform, responding to feedback from a growing user base. The... Read More
-
Late stage prostate cancer inhibitor targeted at the US
CellCentric in Cambridge is beginning clinical testing of CCS1477, a novel, first-in-class drug for late-stage prostate cancer, following regulatory... Read More
-
US FDA backs GW treatment of rare child epilepsies
United States medical watchdog, the FDA, has approved a cannaboid-based solution from GW Pharmaceuticals in Cambridge and its US subsidiary Greenwich... Read More
-
Ubisense wins £multimillion deal to supply military training base
Location technology from quoted Cambridge company Ubisense is being used in one of the most advanced military training facilities on the planet in a... Read More
-
Trustonic secures PlayCoin cryptocurrency for GameHub
The online gaming industry continues to grow, making it an attractive proposition for investors and developers. Unfortunately, this... Read More
-
Azuri broadens capability in Kenya
Cambridge business Azuri Technologies, the first company to launch a complete pay-as-you-go solar TV package in Kenya, has announced a partnership... Read More
-
Daimler puts Ubisense in driving seat
Ubisense Group plc, a global leader in enterprise location intelligence solutions, is supporting German carmaker Daimler by rolling out its... Read More
-
Bango cashing in on Cambridge cachet
Cambridge’s heightened reputation as a global cradle of technology innovation is helping mobile commerce business Bango recruit world-class talent... Read More
-
Darktrace joins A-list
Cambridge-based Darktrace, the world’s leading AI company for cyber defence, has been named one of Fast Company’s 50 ‘World’s Most Innovative... Read More
-
Accelerated growth for genomic data platform Repositive
Repositive, the technology startup immersed in building a global genomic data marketplace from its headquarters in Cambridge, has attracted platform... Read More
-
Endomag marker receives new FDA clearance
Endomag, the Cambridge-based surgical guidance company, has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to extend the... Read More
-
Adaptable rail carriage on track for commercial trials
UK transport minister Jo Johnson has revealed that 42 Technology has been awarded almost £350K by Innovate UK, the UK’s innovation agency, to help... Read More
-
Abcam and US partner target slice of $25 billion market
A Cambridge-California partnership has been forged between Abcam and Molecular Devices to target a key segment of an immunoassay market forecast to... Read More
-
Abcam signs licence deal with Roche
Abcam plc in Cambridge, which supplies life science research tools, has entered into a definitive licence agreement with Roche. Financial terms have... Read More
-
Nobel Prize winner becomes STORM scientific adviser
Nobel Prize winner Professor Thomas Cech has been named as a scientific adviser at Cambridge-based STORM Therapeutics, a drug discovery company... Read More